Generation of functional dendritic cells (DC) in adult acute lymphoblastic leukemia: rationale for a DC-based vaccination program for patients in complete hematological remission
/in Acute Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma /von 2007-02-01 / Leuk. Lymphoma 2007 Feb;48(2):302-10Gene expression in enhanced apoptosis of human lymphoma U937 cells treated with the combination of different free radical generators and hyperthermia
/in Hyperthermia, International Publications, Malignant Lymphoma /von 2007-01-01 / Free Radic. Res. 2007 Jan;41(1):73-81Current status of immunotherapy in B cell malignancies
/in Chronic Leukemia, Dendritic Cells, International Publications, Malignant Lymphoma, Multiple Myeloma /von 2006-10-01 / Curr Drug Targets 2006 Oct;7(10):1371-4Analysis of cell proliferation and cell death during in situ hyperthermic treatment of neoplastic cells: a case report of human non-Hodgkin lymphoma
/in Hyperthermia, International Publications, Malignant Lymphoma /von 2006-05-24 / Biomed. Pharmacother. 2006 Jun;60(5):227-32Antigen targeting to endosomal pathway in dendritic cell vaccination activates regulatory T cells and attenuates tumor immunity
/in International Publications, Malignant Lymphoma /von 2006-04-18 / Blood 2006 Aug;108(4):1298-305Autologous dendritic cells pulsed with eluted peptide as immunotherapy for advanced B-cell malignancies
/in Chronic Leukemia, International Publications, Malignant Lymphoma /von 2006-04-01 / Leuk. Lymphoma 2006 Apr;47(4):675-82Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin’s lymphoma and multiple myeloma
/in International Publications, Malignant Lymphoma /von 2006-03-07 / Ann. Hematol. 2006 May;85(5):308-14Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96
/in International Publications, Malignant Lymphoma /von 2005-12-15 / Clin. Cancer Res. 2005 Dec;11(24 Pt 1):8808-15Natural killer cells license dendritic cell cross-presentation of B lymphoma cell–associated antigens
/in International Publications, Malignant Lymphoma /von 2005-12-15 / Clin. Cancer Res. 2005 Dec;11(24 Pt 1):8763-72IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de